Susquehanna Fundamental Investments’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-247,607	Closed	-$636K	–	1037
2024 Q1	$636K	Buy	+247,607	New	+$605K	0.03%	429
2023 Q4	–	Sell	-21,570	Closed	-$37.1K	–	353
2023 Q3	$37.1K	Sell	21,570 -8,977	-29%	-$15.9K	﹤0.01%	354
2023 Q2	$59.6K	Hold	30,547	–	–	﹤0.01%	618
2023 Q1	$84.9K	Hold	30,547	–	–	﹤0.01%	907
2022 Q4	$105K	Buy	+30,547	New	+$87.2K	﹤0.01%	1114
2022 Q1	–	Sell	-54,700	Closed	-$703K	–	1722
2021 Q4	$703K	Buy	54,700 +10,900	+25%	+$121K	0.02%	790
2021 Q3	$473K	Sell	43,800 -20,367	-32%	-$185K	0.01%	1238
2021 Q2	$586K	Sell	64,167 -2,760	-4%	-$25.5K	0.01%	1092
2021 Q1	$631K	Buy	66,927 +460	+0.7%	+$6.33K	0.01%	1068
2020 Q4	$262K	Sell	66,467 -7,589	-10%	-$23K	﹤0.01%	1293
2020 Q3	$196K	Buy	74,056 +54,693	+282%	+$203K	0.01%	1202
2020 Q2	$129K	Buy	+19,363	New	+$130K	0.01%	887

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna Fundamental Investments's GRTS Position: Q2 2024 in Review

Susquehanna Fundamental Investments sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 247,607 shares — an estimated $636K sold.

Susquehanna Fundamental Investments first reported a position in GRTS in Q2 2020 and held it in 12 quarters. The position peaked at $703K in Q4 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

Susquehanna Fundamental Investments reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Susquehanna Fundamental Investments sold 247,607 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $636K.
Susquehanna Fundamental Investments first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
Susquehanna Fundamental Investments's Gritstone bio, Inc. Common Stock position peaked at $703K in Q4 2021.
79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.